Explore 3 Stock Ideas & Industry Insights Download Free Report

News

IQSTEL Posts $313M Nine-Month Revenue, Up 34.5%

IQSTEL Inc. filed its quarterly earnings press release on November 16, 2026, reporting consolidated revenue of $313.0 million for the nine months ended September 30, 2026, alongside third-quarter and segment-level financial results.

Manish Choudhary | 16 November 2026

Bitmine Reports $11.8B Holdings, 4.97% ETH Supply Share

Bitmine Immersion Technologies, Inc. released a press release on November 16, 2026, disclosing total crypto, cash, marketable securities, and "moonshot" holdings of $11.8 billion and announcing that the company holds 4.97% of the total ETH coin supply as of November 15, 2026.

Vinay Lochav | 16 November 2026

RTW Investments Reports 9.5% Stake in iRhythm Holdings

RTW Investments, LP and Roderick Wong, M.D. filed Amendment No. 2 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 3,118,913 shares of iRhythm Holdings, Inc. common stock as of September 30, 2026.

Nitish Kishor | 16 November 2026

RTW Fund Group Reports 9.9% Stake in Yarrow Bioscience

RTW Fund Group GP, LLC and its Managing Member Roderick Wong filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing a combined 9.9% interest in Yarrow Bioscience, Inc. as of September 30, 2026.

Aditi Sarkar | 16 November 2026

Deep Track Capital Holds 6M Nurix Shares at 5.49%

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed Amendment No. 4 to their Schedule 13G with the SEC on November 16, 2026, disclosing a combined beneficial ownership position in Nurix Therapeutics, Inc. common stock as of September 30, …

Shwetambri Chauhan | 16 November 2026

Deep Track Reports 15M Shares in Structure Therapeutics

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed Amendment No. 5 to Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common shares in Structure Therapeutics Inc. as of September 30, 2026.

Shwetambri Chauhan | 16 November 2026

Iroquois Capital Files Amended 13G on SCWorx, Holds 9.99%

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed Amendment No. 7 to a Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common stock in SCWorx Corp. as of September 30, 2026.

Nitish Kishor | 16 November 2026

Iroquois Group Reports 7.93% Stake in Auddia Inc.

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership positions in Auddia Inc. (NASDAQ:AUUD) as of September 30, 2026.

Anjali Anand | 16 November 2026

Corebridge Reports 9.5% Stake in Carlyle Tactical Private Credit Fund

Corebridge Financial, Inc. filed Amendment No. 3 to Schedule 13G on November 16, 2026, disclosing beneficial ownership of 4,000,000 shares, representing 9.5% of the outstanding securities of Carlyle Tactical Private Credit Fund as of September 30, 2026.

Nitish Kishor | 16 November 2026

Highbridge Discloses 5.8% Warrant-Based Stake in TOYO

Highbridge Capital Management, LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 2,619,799 ordinary shares of TOYO Co., Ltd (NASDAQ:TOYO), representing 5.8% of the outstanding class, with all shares issuable upon exercise of warrants held by …

Nitish Kishor | 16 November 2026
Support

Hi! How can we help you today?

Loading…